M, Z., S, K., A, S., Z, D., P, L., R, Z., . . . D, P. (2024). Real-World Maintenance Phase Persistence on Ustekinumab and Adalimumab in Ulcerative Colitis. Patient Preference and Adherence, ume 18, 809-820.
Chicago Style (17th ed.) CitationM, Zhdanava, Kachroo S, Shah A, Ding Z, Lefebvre P, Zhao R, Kerner C, and Pilon D. "Real-World Maintenance Phase Persistence on Ustekinumab and Adalimumab in Ulcerative Colitis." Patient Preference and Adherence ume 18 (2024): 809-820.
MLA (8th ed.) CitationM, Zhdanava, et al. "Real-World Maintenance Phase Persistence on Ustekinumab and Adalimumab in Ulcerative Colitis." Patient Preference and Adherence, vol. ume 18, 2024, pp. 809-820.
Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.
Visit our Citation Styles guide for help on properly citing sources.